CytImmune Sciences, Inc – TechConnect Briefs

Cancer Nanomedicines: Challenges and Opportunities

Tamarkin L., CytImmune Sciences, Inc, US

The treatment of cancer remains an ever-growing problem. Treating solid tumors as a medical disease first, using the natural biology of tumors to reduce or eliminate tumors in situ, offers patients and the entire healthcare [...]

Colloidal Gold Nanoparticles: A Versatile Platform for Developing Tumor Targeted Cancer Therapies

Paciotti G.F., Myer L., Kingston D.G.I., Ganesh T., Tamarkin L., CytImmune Sciences, Inc, US

CytImmune Sciences is developing colloidal gold nanoparticles (cAu) as a platform for tumor targeted drug delivery. Specifically two drugs are discussed: Aurimune-T and AuriTax. Aurimune-T is manufactured by covalently linking molecules of TNF and Thiol-derivatized [...]